Current concepts in the diagnosis and management of cytokine release syndrome. - Wikidata - wikimedia - TriplyDB

Current concepts in the diagnosis and management of cytokine release syndrome.

Current concepts in the diagnosis and management of cytokine release syndrome.

http://www.wikidata.org/entity/Q33886879

about

The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy Critical care of patients with cancer Chimeric antigen receptor T-cell therapy for solid tumors Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances Novel immunotherapies in lymphoid malignancies Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)T-Cell Therapy: Options for Infectious Diseases Immunotherapy of Childhood Sarcomas Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors Antibody-based immunotherapy of solid cancers: progress and possibilities Clinical development methodology for infusion-related reactions with monoclonal antibodies Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street The Evolution of T-cell Therapies for Solid Malignancies CAR T Cell Therapy: A Game Changer in Cancer Treatment T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect Blinatumomab: enlisting serial killer T-cells in the war against hematologic malignancies Using gene therapy to manipulate the immune system in the fight against B-cell leukemias Review of siltuximab in the treatment of multicentric Castleman's disease Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination Toxicity and management in CAR T-cell therapy Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab CAR therapy: the CD19 paradigm T cell engineering as therapy for cancer and HIV: our synthetic future CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia Smart CARs engineered for cancer immunotherapy Designing chimeric antigen receptors to effectively and safely target tumors Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial Reappraising the timing of transplant for indolent non-Hodgkin lymphomas.Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 1.Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.Immunotherapy in hematologic malignancies: past, present, and future.Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells

P2860

Q26744280-C801D019-D9B3-4A89-A635-A8CBA45E08AC Q26744654-CD863C76-DB87-4B05-856F-786D0ABD7D18 Q26746976-C633DA2A-5E59-4412-A2A8-F0109A68BF25 Q26750908-0176FE2E-6D71-47C5-8301-09EB1F68AE9C Q26775720-825B5F14-9DAA-4144-8B10-581F1C22033E Q26777394-E264A640-AFC8-4F9B-A7F6-68F2DFDB10C7 Q26783175-26641A6E-772C-4377-95FB-4F41FF0A1AE8 Q26783433-7F78A60F-450D-4FDB-B7FA-EFCFDE6FD6A4 Q26786661-F479579D-D438-4AB9-8C05-C5D5250CAA83 Q26795369-C41CDC74-4550-4AA4-86C4-01929E7AE5AE Q26795540-C4A84AFB-D93F-4D74-B8B7-0FAA529F7D88 Q26796542-00949409-7ADE-46FA-88EC-1C61295F0433 Q26798184-9CB7D59A-A9F6-4282-B1F0-9FBC3BA10D20 Q26799357-3FC11776-CDE2-4C28-934C-20241DAF557B Q26799372-A2F36911-DE59-4D4B-A587-544F4FFEA977 Q26822769-5BFC963B-6229-4285-88D7-6839F1154B84 Q26826830-3C62C089-B416-4160-8AA7-05899AD78D45 Q26865838-B6654B05-68A0-43DF-91EA-DE1F3EDE14F2 Q27011297-5BB27EC5-E577-463D-98DE-446E5A41A49F Q28067246-CDF21F39-4598-4D43-9591-4E7E0952233E Q28068378-BCF16EFE-11A3-4851-A454-BF3CD0B4A9FA Q28075314-A7FC9BEC-76D1-49FD-94D5-CDE7644B56DD Q28079823-10D85E18-A133-4241-B183-E563302EF9DF Q28079934-60ADF2E4-32A2-47D3-B36D-5E1A8B1CAE54 Q28081642-A3B82C0D-237D-443B-8583-E6782B629EDA Q28082253-841B8DE1-A1FA-4EAB-B1AC-D3187442F434 Q28084879-0CEFEFB2-D28D-4F52-8EBE-0917431F0BAD Q28087236-76E428A7-5680-44D9-A656-57F0603A46B5 Q28088526-62B79928-5910-481E-8488-59E0DC5FDC0F Q28551448-2BF7CF6E-ADE7-4A92-BCA3-FF4E7C86146D Q30248407-E0D889D4-178E-43AE-90CA-485B7FE38C11 Q30253063-F2C9948C-F07B-4CC4-9427-F1982694EE98 Q33439759-A5889B2F-112C-40AA-91F2-D4ADA6C29895 Q33564364-00761128-0D4D-46C2-B569-7E0515AD193E Q33564645-74F1CCE1-C7A3-482C-8C90-7953BD60F89A Q33593865-81A08841-A4A6-4AF3-85FC-BF12A90135FB Q33700795-FDF15E5D-2ED8-430B-9AD3-1931677A0F00 Q33738328-40E5ED78-40F1-452A-BF07-DB00176DC524 Q33823270-BA532930-07D8-41F8-9E98-5547F074339E Q33833475-F17DDAC6-DCAB-4AA8-BEA6-AADD1FF2CF8C

P2860

Current concepts in the diagnosis and management of cytokine release syndrome.

http://www.wikidata.org/entity/Q33886879

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Current concepts in the diagnosis and management of cytokine release syndrome.

@ast

Current concepts in the diagnosis and management of cytokine release syndrome.

@en

type

label

Current concepts in the diagnosis and management of cytokine release syndrome.

@ast

Current concepts in the diagnosis and management of cytokine release syndrome.

@en

prefLabel

Current concepts in the diagnosis and management of cytokine release syndrome.

@ast

Current concepts in the diagnosis and management of cytokine release syndrome.

@en

P1433

Q33886879-97DA887D-AE68-4C90-9851-64BF6480125C

P1476

Q33886879-077E46F6-3A2D-42D7-B2E7-220FFAC0CA9F

P2093

Q33886879-023D6210-0E57-4D3D-AB58-2ED3A0B680DB

Q33886879-446E4FCB-1B81-4B88-A40B-B9B2E8CDB4EF

Q33886879-489924FA-6342-4072-A220-D84A2E96E717

Q33886879-6D329A0E-3446-410D-873F-0747EB51D19F

Q33886879-8226FBA9-B043-4E0A-8AE7-EC7588FD50CF

Q33886879-90CFC9FC-7318-4DFB-834E-5AD7EEAF6F2B

Q33886879-9F912282-CD2C-492A-8153-F7BE0488A280

Q33886879-A6CC2316-6064-42A5-B3C9-541C01E930CF

P2860

Q33886879-02737D73-4C66-4E0A-867D-580C172D9AE2

Q33886879-04EB1622-5E57-4119-886B-C1FE4370DB04

Q33886879-07E65671-9D3E-4523-A79E-19B2FEB8D289

Q33886879-0E098716-2F6A-4BE6-AD25-78AA55688973

Q33886879-13DABF82-EAFA-4FF3-94CE-B693855AEB0B

Q33886879-1571F3DA-73C5-46FA-A012-13A85F1C135E

Q33886879-23084189-0AA9-4708-A923-E9F0A0D5CA98

Q33886879-3378710D-C9A7-44C4-A84C-43F817791285

Q33886879-44B63C68-2DB0-44F7-A43C-A9B77B39EEFD

Q33886879-48203C3A-3ACB-4EEC-B118-4FE20BC78E8F

P304

Q33886879-6115888B-EC36-4840-8AED-B01A3BF9258B

P31

Q33886879-1D6DDED7-85C7-4C56-A5A7-04B8761CF331

P356

Q33886879-5C65F37C-BEDF-4184-807E-6BC431DA371C

P407

Q33886879-4DD16A9B-8CC0-4EB3-99B0-ACBFF6C22083

P433

Q33886879-49CF774A-C719-4F4E-9362-72D19936645A

P478

Q33886879-9F03793C-5B1E-4A54-B3F0-6440122DBBA6

P577

Q33886879-96A9DE7F-C473-4C1D-8717-8D39EF9B0A10

P5875

Q33886879-59B3C055-133A-4C1B-A5C6-C03CB4E1C9FF

P698

Q33886879-3E94DD04-7C4C-4C3C-AF30-37EB1F2CB0FB

P932

Q33886879-40FD0482-6496-4C99-AB5E-B208A78CCB3C

P356

BLOOD-2014-05-552729

P1433

P1476

Current concepts in the diagnosis and management of cytokine release syndrome.

@en

P2093

Chrystal U Louis

http://www.w3.org/2001/XMLSchema#string

Crystal L Mackall

http://www.w3.org/2001/XMLSchema#string

Daniel W Lee

http://www.w3.org/2001/XMLSchema#string

David L Porter

http://www.w3.org/2001/XMLSchema#string

Michael Jensen

http://www.w3.org/2001/XMLSchema#string

Nabil Ahmed

http://www.w3.org/2001/XMLSchema#string

Rebecca Gardner

http://www.w3.org/2001/XMLSchema#string

Stephan A Grupp

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Rituximab: mechanism of action

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

C-reactive protein: a critical update

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

P304

188-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-05-552729

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262787181

http://www.w3.org/2001/XMLSchema#string

P698

24876563

http://www.w3.org/2001/XMLSchema#string

P932

4093680

http://www.w3.org/2001/XMLSchema#string